India’s COVID Cases Drop After Government Promotes ‘Trump Drugs’

India has become the center of the novel coronavirus pandemic, but a drop in cases has coincided with the national health ministry’s promotion of ivermectin and hydroxychloroquine treatments.

The India Ministry of Health and Family Welfare updated its guidelines on April 28 for treating the asymptomatic and those with mild symptoms of COVID-19

Since then, the data show cases have plunged in some areas, reported a leading promoter in the United States of ivermectin as a treatment for COVID-19, Dr. Pierre Kory, the COVID blog reported.

On Monday, Indian officials announced the country’s daily COVID-19 cases fell below 300,000 for the first time in 25 days.

Kory, the chief medical officer of the Front Line Covid-19 Critical Care Alliance, is known for his congressional testimony about the effectiveness of ivermectin. In a live Zoom conference May 13, he showed the promising data from various states in India in the two weeks since ivermectin has been promoted. (Read more from “India’s COVID Cases Drop After Government Promotes ‘Trump Drugs'” HERE)

Delete Facebook, Delete Twitter, Follow Restoring Liberty and Joe Miller at gab HERE.